학술논문
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
Document Type
Article
Author
Source
In Oral Oncology June 2017 69:38-45
Subject
Language
ISSN
1368-8375